MedTrace Logo

Influenza Diagnosis, Treatment and Surveillance With Xpert Flu

NCT01947049 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 2011

Last updated 2017-09-18

No results posted yet for this study

Summary

The purpose of this study is to:

1. Evaluate the clinical performance of a newly available highly-sensitive rapid influenza test, Xpert Flu.
2. Derive and validate an adult clinical decision guideline to guide clinical testing of influenza patients who meed CDC criteria for antiviral treatment.
3. Evaluate impact of rapid influenza testing for antiviral treatment.
4. Determine cost effectiveness of influenza testing and treatment strategies.

Conditions

Interventions

OTHER

Rapid Influenza Testing with Xpert Flu

Participants with recieve rapid influenza testing with Xpert Flu

Sponsors & Collaborators

Principal Investigators

  • Andrea Dugas, MD · Johns Hopkins University

  • Richard Rothman, MD, PhD · Johns Hopkins University

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-07-31
Primary Completion
2014-06-30
Completion
2014-06-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01947049 on ClinicalTrials.gov